Nanjing, China

Liqin Yu

This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: Beijing Innocare Pharma Tech Co., Ltd.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Liqin Yu. Retrieved from https://idiyas.com/inventor/liqin-yu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Inventor Liqin Yu

Introduction

Liqin Yu is a notable inventor based in Nanjing, China. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patents. With a total of two patents to his name, his work focuses on improving drug formulations and bioavailability.

Latest Patents

Liqin Yu's latest patents include an amorphous solid dispersion comprising 6-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)nicotinamide. This invention relates to a stable amorphous solid dispersion that enhances the dissolution rate and bioavailability compared to its crystalline form. His second patent involves various crystalline forms of the same compound, which also includes pharmaceutical compositions that utilize these forms.

Career Highlights

Liqin Yu is currently associated with Beijing Innocare Pharma Tech Co., Ltd. His work at this company has allowed him to focus on developing innovative pharmaceutical solutions that address critical needs in drug delivery and efficacy.

Collaborations

Some of his coworkers include Xiangyang Chen and Zuopeng Wang, who contribute to the collaborative efforts in research and development within the company.

Conclusion

Liqin Yu's contributions to pharmaceutical innovations through his patents demonstrate his commitment to enhancing drug formulations. His work continues to impact the field positively, paving the way for improved therapeutic options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…